ANACOR PHARMACEUTICALS INC COM
ANAC
ANAC was delisted on the 23rd of June, 2016.
105 hedge funds and large institutions have $653M invested in ANACOR PHARMACEUTICALS INC COM in 2014 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 40 increasing their positions, 27 reducing their positions, and 8 closing their positions.
250% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 8
48% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 27
22% more capital invested
Capital invested by funds: $535M → $653M (+$118M)
21% more funds holding
Funds holding: 87 → 105 (+18)
17% more call options, than puts
Call options by funds: $1.03M | Put options by funds: $880K
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$23.8M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$22.1M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$11.5M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.06M |
| 5 |
State Street
Boston,
Massachusetts
|
+$7.72M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCP
Rho Capital Partners
New York
|
-$58.2M |
| 2 |
SCA
SAC Capital Advisors
Stamford,
Connecticut
|
-$10.2M |
| 3 |
BC
Broadfin Capital
New York
|
-$10M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.98M |
| 5 |
KCM
Kingdon Capital Management
New York
|
-$8.37M |
ANAC Hedge Fund Activity: Q1 2014 in Review
105 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q1 2014, worth a combined $653M — up 22% from $535M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new ANAC positions and 8 closed out — a net gain of 20 holders — while 40 added to existing stakes and 27 trimmed.
The largest buyer was Eagle Asset Management, opening a new position worth an estimated $23.8M. The largest seller was Rho Capital Partners, cutting an estimated $58.2M.
- 105 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q1 2014, up from 87 in Q4 2013.
- Funds reported $653M of ANACOR PHARMACEUTICALS INC COM stock for Q1 2014, up 22% quarter-over-quarter.
- 28 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q1 2014 and 8 closed out, a net change of +20 holders.
- The largest ANACOR PHARMACEUTICALS INC COM buyer in Q1 2014 was Eagle Asset Management, an estimated $23.8M added.
- The largest ANACOR PHARMACEUTICALS INC COM seller in Q1 2014 was Rho Capital Partners, an estimated $58.2M sold.
Based on aggregated 13F filings for Q1 2014.